Ordenar

Buscar

01/11/2025 Prophylactic Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement
Fischer, Q, Nombela-Franco, L, Muntané-Carol, G, Veiga, G, Regueiro, A, Nazif, T, Serra, V, Asmarats, L, Ribeiro, HB, Latib, A, Poulin, A, Cheema, AN, Tirado-Conte, G, Gomez-Hospital, JA, Ongay, AG, Gabani, R, Arzamendi, D, Brener, M, Calabuig, A, Scotti, A, Gelain, MAS, Labinaz, M, Cepas-Guillén, P, Côté, M, del Portillo, JH, Philippon, F, Rodés-Cabau, J. Prophylactic Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement. JACC-Clinical Electrophysiology. 2025; 11(11)DOI:10.1016/j.jacep.2025.07.028. PMID:40965381. IF:7.700(Q1/1D).
01/11/2025 Refractory congestion following successful pericardiocentesis for cardiac tamponade: effusive-constrictive pericarditis caused by Cutibacterium acnes
Santaló-Corroy, M, Triguero-Llonch, L, Fernández-Martinez, J, Arias-Pinilla, JP, Ferrer-Menéndez, M, Bonet-Basiero, A. Refractory congestion following successful pericardiocentesis for cardiac tamponade: effusive-constrictive pericarditis caused by Cutibacterium acnes. REVISTA ESPANOLA DE CARDIOLOGIA. 2025; 78(11)DOI:10.1016/j.rec.2025.06.009. PMID:40812677. IF:4.900(Q1/2D).
01/11/2025 Sex differences in mitral regurgitation anatomy and outcomes of transcatheter edge-to-edge repair
Li, CHP, Asmarats, L, van Roessel, AM, Capellades, H, Fernández-Peregrina, E, Arzamendi, D. Sex differences in mitral regurgitation anatomy and outcomes of transcatheter edge-to-edge repair. REVISTA ESPANOLA DE CARDIOLOGIA. 2025; 78(11)DOI:10.1016/j.rec.2025.01.018. PMID:39938677. IF:4.900(Q1/2D).
01/11/2025 Clinicopathological and molecular features of recurrence in ctDNA-negative resected colorectal cancer
Beltran, JS, Pérez, MARSM, Manrique, ACV, Cullell, BM, Munoz, MN, Mateo, FJP, Riera, P, Fuste, V, Fumagalli, C, Szafranska, J, Catasus, L, Gonzalez, A, Paez, D. Clinicopathological and molecular features of recurrence in ctDNA-negative resected colorectal cancer. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.08.1344. PMID:. IF:65.400(Q1/1D).
01/11/2025 Methotrexate-Induced Gouty Arthritis in Psoriatic Patient
Carmona-Rocha, E, Torné, CD, Alonso, AML, Puig, L. Methotrexate-Induced Gouty Arthritis in Psoriatic Patient. Actas Dermo-Sifiliograficas. 2025; 116(10)DOI:10.1016/j.ad.2024.02.050. PMID:40615030. IF:(Q/D).
01/11/2025 Defining molecular correlates of response using spatial transcriptomics in the SOGUG-AUREA trial
Ballesteros, PA, García-Carbonero, I, Gonzalez, EE, Marin, AP, Lorente, D, de Liaño, AG, Ortega, EM, Colomo, LJ, Puente, J, Gonzalez, I, Calvo, OF, Palacios, GA, Mendizabal, I, Navarro, EP, Domínguez, JID, Esteban-Villarrubia, J, Billalabeitia, EG, Oria, GAD. Defining molecular correlates of response using spatial transcriptomics in the SOGUG-AUREA trial. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.08.3696. PMID:. IF:65.400(Q1/1D).
01/11/2025 Characterization of locally advanced rectal cancer (LARC) patients (pt) in Spanish TTD-RETUD registry
España, MAG, Calle, SG, Flores, EG, Sosa, MM, Tocino, RV, Plazas, JG, Monteagudo, RF, Aguilera, MJS, Herrero, MDRM, Gargia, TG, Zafra, GM, Arévalo, MA, Orozco, EJ, Manrique, ACV, Alfonso, PG, Montes, AF, Ninerola, RQ, de Castro, EM, Verdaguer, H, García, RV. Characterization of locally advanced rectal cancer (LARC) patients (pt) in Spanish TTD-RETUD registry. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.08.1362. PMID:. IF:65.400(Q1/1D).
01/11/2025 Exploratory analysis of chromophobe renal cell carcinoma in the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first-line treatment
Ahrens, M, Haanen, JBAG, Albiges, L, Goupil, MG, Boleti, E, Gravis, G, Flechon, A, Grimm, MO, Bedke, J, Barthelemy, P, Gauna, DEC, Gonzalez, BM, Ivanyi, P, Rottey, S, Floercken, A, Rodriguez, CS, Rey, JPM, Burkholder, I, Hartmann, A, Bergmann, L. Exploratory analysis of chromophobe renal cell carcinoma in the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first-line treatment. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.08.3211. PMID:. IF:65.400(Q1/1D).
01/11/2025 Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON Study
Sanborn, RE, Zhou, CC, Tang, KJ, Cho, BC, Cheng, S, Popat, S, Ono, A, Lu, S, Majem, M, Aguilar, A, Campelo, MDG, Hayashi, H, Lee, KY, Lee, SH, Delmonte, A, Alatorre-Alexander, J, Richardson, G, Santos, V, Dooms, C, Sabari, JK, Shu, CA, Girard, N, Mansfield, AS, Park, K, Xia, YC, Bhattacharya, A, Buyukkaramikli, N, Perualila, N, Diels, J, Acharya, S, Chandler, C, Proskorovsky, I, Dearden, L, Wortman-Vayn, H, Mahadevia, PJ, Knoblauch, RE, Agrawal, T, Baig, M, Felip, E. Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON Study. Targeted Oncology. 2025; 20(6)DOI:10.1007/s11523-025-01182-0. PMID:41184595. IF:4.000(Q2/3D).
01/11/2025 Real-world outcomes after immunotherapy discontinuation in advanced melanoma: Insights from the GEM1801 study
Muñoz-Couselo, E, Berciano-Guerrero, MA, Crespo, G, Castaño, AG, Manzano, JL, Miguel, PAD, Rosa, CA, Cerezuela-Fuentes, P, Puértolas, T, Sanz, LG, Medina, J, Cunquero-Tomás, A, Majem, M, Fernández, LA, Espinosa, E, Bellido, L, Soria, A, Bujosa, A, Algarra, SM, Marquez-Rodas, I. Real-world outcomes after immunotherapy discontinuation in advanced melanoma: Insights from the GEM1801 study. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.08.2263. PMID:. IF:65.400(Q1/1D).
01/11/2025 Relevance of the CPS score and tumor nephrectomy in the SUNNIFORECAST trial comparing ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer
Bergmann, L, Albiges, L, Ahrens, M, Goupil, MG, Boleti, E, Gravis, G, Flechon, A, Grimm, MO, Bedke, J, Barthelemy, P, Gauna, DEC, Gonzalez, BM, Ivanyi, P, Floercken, A, Rodriguez, CS, Rey, JPM, Gruenwald, V, Burkholder, I, Hartmann, A, Haanen, JBAG. Relevance of the CPS score and tumor nephrectomy in the SUNNIFORECAST trial comparing ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.08.3216. PMID:. IF:65.400(Q1/1D).
01/11/2025 International multicenter retrospective study of spindle cell/ sclerosing rhabdomyosarcoma (S-RMS): A PUSH platform study
Chen, TWW, Giani, C, Ljevar, S, Reinhorn, D, Denu, R, Bhadri, VA, Jaeger, R, Ibrahim, T, D'Ambrosio, L, Bae, S, Han, I, Garcia, AS, Abreu, MH, Ribeiro, MFSA, Mariuk-Jarema, A, Yang, V, Sbaraglia, M, Antonescu, C, Baldi, GG, Stacchiotti, S. International multicenter retrospective study of spindle cell/ sclerosing rhabdomyosarcoma (S-RMS): A PUSH platform study. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.08.3306. PMID:. IF:65.400(Q1/1D).
01/11/2025 Phase II of sunitinib plus nivolumab in advanced alveolar soft-part sarcoma results from the GEIS, ISG and UCL IMMUNOSARC II study
Muñiz, NH, Strauss, S, Redondo, A, Palmerini, E, Gaffaro, GJM, Chamberlain, FE, Martinez, V, Ibrahim, T, Trufero, JM, Morales, CMV, Billalabeitia, EG, Lleida, RT, Jiménez, CL, Mukherjee, U, Wan, S, Ramos, R, Garcia, AMG, Moura, DD, Martin-Broto, J. Phase II of sunitinib plus nivolumab in advanced alveolar soft-part sarcoma results from the GEIS, ISG and UCL IMMUNOSARC II study. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.08.3296. PMID:. IF:65.400(Q1/1D).
01/11/2025 Evaluation of a non-pharmacological skin care intervention for the prevention and treatment of skin toxicities induced by immunotherapy in oncology patients
Lopez, JS, Besora, CP, Malaret, M, Joaquín, AB, Recio, SM, Momblan, AM, Dalmau, GM, Majem, M. Evaluation of a non-pharmacological skin care intervention for the prevention and treatment of skin toxicities induced by immunotherapy in oncology patients. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.08.3451. PMID:. IF:65.400(Q1/1D).
01/11/2025 Navigating regulatory complexity in combined studies under clinical trial and in vitro diagnostic regulations: Lessons from the CHONQUER study on molecular prescreening for IDH1 mutation in chondrosarcoma
Blay, JY, Lleida, RT, Martin-Broto, J, Caetano, C, De Haan, JJ, Debruyne, C, Desar, I, Duffaud, F, Gelderblom, H, Gennigens, C, Italiano, A, Colomo, LJ, Lapeire, L, Mazzeo, F, Philip, J, Striefler, JK, Svobodova, M, Tala, I, Morales, CMV, Stacchiotti, S. Navigating regulatory complexity in combined studies under clinical trial and in vitro diagnostic regulations: Lessons from the CHONQUER study on molecular prescreening for IDH1 mutation in chondrosarcoma. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.08.3359. PMID:. IF:65.400(Q1/1D).
01/11/2025 Personalizing antiemetic prophylaxis for patients at high emetic risk: Results from the MyRisk Trial
Molasiotis, A, Jordan, K, Karthaus, M, Dranitsaris, G, Roeland, EJ, Schwartzberg, LS, Bonizzoni, E, Vazquez, EB, Buchler, T, Cheng, Y, Christoph, DCC, Alfonso, PG, Lu, X, Majem, M, Mavroudis, D, Syrigos, K, Tomlins, E, Zhou, Z, Zimovjanova, M, Aapro, MS. Personalizing antiemetic prophylaxis for patients at high emetic risk: Results from the MyRisk Trial. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.08.3413. PMID:. IF:65.400(Q1/1D).
01/11/2025 Circulating tumor DNA (ctDNA) for minimal disease detection in oropharyngeal cancer (OPC): results from the CAPTION Spanish prospective study
Sepulveda, ZV, Tous, S, Quiros, B, Pena, GP, Castro, JB, Serrahima, MP, Galiana, IL, Marí, A, Brunet, A, Bermejo, JO, Cirauqui, BC, Diez, AF, Leon, X, Sumarroca, A, Giner, M, Clavero, O, Goma, M, Pavon, MA, Alemany, L, Bernal, MO. Circulating tumor DNA (ctDNA) for minimal disease detection in oropharyngeal cancer (OPC): results from the CAPTION Spanish prospective study. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.08.2028. PMID:. IF:65.400(Q1/1D).
01/11/2025 Pharmacogenetics in advanced Parkinson's disease
Kulisevsky, J, García-Ruíz, P, Outeiro, TF, Gurevich, T, Klivènyi, P, Van Laar, T, Milanov, I, Pirker, W, Popescu, BO, Toft, M, Szász, JA. Pharmacogenetics in advanced Parkinson's disease. JOURNAL OF NEURAL TRANSMISSION. 2025; 132(11)DOI:10.1007/s00702-025-03057-0. PMID:41222708. IF:4.000(Q1/2D).
01/11/2025 Sertraline treatment prevents motor dysfunction in a Huntington's disease mouse model and functional decline in patients
Garcia-Forn, M, Castany-Pladevall, C, Creus-Muncunill, J, Golbano, A, Escaramís, G, Pérez-Pérez, J, Balantzategi, U, Hernan-Godoy, M, Brito, V, Kulisevsky, J, Martí, E, Pérez-Navarro, E. Sertraline treatment prevents motor dysfunction in a Huntington's disease mouse model and functional decline in patients. Neurotherapeutics. 2025; 22(6)DOI:10.1016/j.neurot.2025.e00716. PMID:40774881. IF:6.900(Q1/1D).
01/11/2025 BioFace3D: An end-to-end open-source software for automated extraction of potential 3D facial biomarkers from MRI scans
Heredia-Lidón, A, Echeverry-Quiceno, LM, González, A, Hostalet, N, Pomarol-Clotet, E, Fortea, J, Fatjó-Vilas, M, Martínez-Abadías, N, Sevillano, X. BioFace3D: An end-to-end open-source software for automated extraction of potential 3D facial biomarkers from MRI scans. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE. 2025; 271DOI:10.1016/j.cmpb.2025.109010. PMID:40818363. IF:4.800(Q1/1D).
01/11/2025 Associations of lifestyle factors with amyloid pathology in persons without dementia
Oomens, JE, Vos, SJB, Maserejian, NN, Boada, M, Didic, M, Engelborghs, S, Fladby, T, van der Flier, WM, Frisoni, GB, Fröhlich, L, Gill, KD, Grimmer, T, Hort, J, Itoh, Y, Iwatsubo, T, Klimkowicz-Mrowiec, A, Landau, SM, Lee, DY, Lleó, A, Martinez-Lage, P, de Mendonça, A, Meyer, PT, Parchi, P, Pardini, M, Parnetti, L, Popp, J, Rami, L, Reiman, EM, Rinne, JO, Rodrigue, KM, Sánchez-Juan, P, Santana, I, Scarmeas, N, Scheltens, P, Skoog, I, Sperling, RA, Stern, Y, Villeneuve, S, Waldemar, G, Wiltfang, J, Zetterberg, H, Alcolea, D, Allegri, RF, Altomare, D, Bateman, RJ, Baiardi, S, Baldeiras, I, Blennow, K, den Braber, A, van Buchem, MA, Byun, MS, Cerman, J, Chen, KW, Chipi, E, Day, GS, Drzezga, A, Ekblad, LL, Förster, S, Fortea, J, Freund-Levi, Y, Frings, L, Guedj, E, Habeck, CG, Handels, R, Hausner, L, Hellwig, S, Jiménez-Bonilla, JF, Juaristi, AI, Kandimalla, R, Kern, S, Kirsebom, BESB, Kornhuber, J, Legdeur, N, Levin, J, Maier, W, Marquié, M, Minatani, S, Morbelli, SD, Mroczko, B, Ntanasi, E, de Oliveira, CR, Orellana, A, Peters, O, Prabhakar, S, Ramakers, IH, Rodríguez-Rodriguez, E, Ruiz, A, Rüther, E, Sakhardande, J, Selnes, P, Silva, D, Soininen, H, Spiru, L, Takeda, A, Teunissen, CE, Tijms, BM, Vermunt, L, Wallin, ÅK, Wiels, W, Yannakoulia, M, Yi, D, Zettergren, A, Ossenkoppele, R, Verhey, FRJ, Visser, PJ, Jansen, WJ. Associations of lifestyle factors with amyloid pathology in persons without dementia. JOURNAL OF ALZHEIMERS DISEASE. 2025; 108(3)DOI:10.1177/13872877251379083. PMID:41234025. IF:3.100(Q2/5D).
01/11/2025 Severe Neutropenia in Infants With Congenital Cytomegalovirus on Antiviral Therapy
Papaevangelou, V, Pedrero-Tomé, R, Syridou, G, Baquero-Artigao, F, Rodríguez-Molino, P, del Rosal, T, Noguera-Julián, A, Ríos-Barnés, M, Fortuny, C, Villaverde, S, Frick, MA, Vallejo, BA, Soler-Palacín, P, Saavedra, J, Karagiannidou, S, Rincón, E, Busselo, IS, Zuriarrain, OM, Calderón, EM, Tagarro, A, Malumbres, M, Colino, E, Llanos, EG, Ruiz, AM, Mateos, MS, Espuny, XB, Alonso-Ojembarrena, A, Ferreras-Antolin, L, Pérez, IC, Posse, AF, Lyall, H, Blázquez-Gamero, D. Severe Neutropenia in Infants With Congenital Cytomegalovirus on Antiviral Therapy. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2025; 44(11)DOI:10.1097/INF.0000000000004905. PMID:40674644. IF:2.200(Q2/3D).
01/11/2025 Longitudinal Characterization of Patient-Ventilator Asynchronies in Acute Hypoxemic Respiratory Failure
de Haro, C, Xifra-Porxas, A, Batlle, M, Sarlabous, L, Santos-Pulpón, V, Mora, V, Suñol, F, Gomà, G, Estela, J, Subirà, C, López-Aguilar, J, Fernández-Gonzalo, S, Godoy-González, M, Fernández, R, Magrans, R, Telias, I, Roca, O, Brochard, L, Blanch, L. Longitudinal Characterization of Patient-Ventilator Asynchronies in Acute Hypoxemic Respiratory Failure. Respiratory Care. 2025; 70(11)DOI:10.1089/respcare.12673. PMID:40441677. IF:2.100(Q3/6D).
01/11/2025 Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) still be part of the Baseline Series?
Fernández, CPH, Borrego, L, Arnau, AMG, Sánchez, TS, Carrillo, JMC, Ninet, VZ, Baldrich, ES, Miquel, FJM, Salvador, JFS, Guijarro, SC, Gilo, AS, García, PM, Triviño, FN, Romero, FT, Serna, MR, Ninot, GM, González, IR, de la Fuente, EG, Nieto, MAP, Guillén, PSP, Pérez, JS, Rodríguez, JJP, Ortega, MEG, Pérez, RG, Doval, IG, Descalzo, MAG. Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) still be part of the Baseline Series?. Actas Dermo-Sifiliograficas. 2025; 116(10)DOI:10.1016/j.ad.2024.10.063. PMID:40024601. IF:(Q/D).
01/11/2025 Oncologic Outcomes of Endoscopic Management of Upper Tract Urothelial Carcinoma: A Systematic Review and Pooled Analysis from the EAU-YAU Urothelial Working Group
Gallioli, A, Uleri, A, Verri, P, Tedde, A, Mertens, LS, Moschini, M, Del Giudice, F, Soria, F, Laukhtina, E, Subiela, JD, Krajewski, W, D'Andrea, D, Mari, A, Marcq, G, Mori, K, Teoh, J, Afferi, L, Albisinni, S, Sanguedolce, F, Palou, J, Breda, A, Pradere, B. Oncologic Outcomes of Endoscopic Management of Upper Tract Urothelial Carcinoma: A Systematic Review and Pooled Analysis from the EAU-YAU Urothelial Working Group. European Urology Focus. 2025; 11(3)DOI:10.1016/j.euf.2025.01.009. PMID:39894734. IF:5.600(Q1/1D).
01/11/2025 Oncological Outcomes in Bacillus Calmette-Guérin-naïve High-risk Non-muscle-invasive Bladder Cancer Patients: A Systematic Review on Current Treatment Strategies and Future Perspectives
Longonia, M, Scilipoti, P, Soria, F, Pradere, B, Krajewski, W, D'Andreaf, D, Mari, A, Del Giudiceh, F, Pichleri, R, Subielaj, JD, Afferik, L, Albisinnil, S, Gallioli, A, Mertens, LS, Laukhtinaf, E, Morio, K, Radziszewskip, P, Slusarczykp, A, Shariat, SF, Necchi, A, Xylinas, E, Gontero, P, Roupret, M, Montorsi, F, Briganti, A, Moschini, M. Oncological Outcomes in Bacillus Calmette-Guérin-naïve High-risk Non-muscle-invasive Bladder Cancer Patients: A Systematic Review on Current Treatment Strategies and Future Perspectives. European Urology Oncology. 2025; 8(5)DOI:10.1016/j.euo.2025.03.007. PMID:40204534. IF:9.300(Q1/1D).
01/11/2025 Challenges in Follow-up After Kidney-sparing Surgery for Upper Tract Urot helial Carcinoma: Insights from a Delphi Consensus
Figaroa, O, Schuil, H, Kamphuis, G, van den Brink, L, Hendriks, N, Henderickx, M, Bins, A, van Moorselaar, J, Ajayi, L, Bus, M, Cavadas, V, Cracco, CM, Andrea, DD, Dasgupta, R, De Coninck, V, Durutovic, O, Ebbensgaard, I, Ferretti, S, Gallioli, A, Keller, EX, Keeley, FX Jr, Osther, PJS, Popiolek, M, Pradere, B, Proietti, S, Saltirov, I, Somani, B, Tailly, T, Thomas, K, Turney, B, Ulvik, O, van Haute, C, van der Heij, B, Vasquez, JL, Brehmer, M, Baard, J. Challenges in Follow-up After Kidney-sparing Surgery for Upper Tract Urot helial Carcinoma: Insights from a Delphi Consensus. European Urology Oncology. 2025; 8(5)DOI:10.1016/j.euo.2025.07.003. PMID:40816958. IF:9.300(Q1/1D).
01/11/2025 Understanding ICU Outcomes: Lessons From National ICU Registries
Moralez, GM, Ranzani, OT, Quintairos, A, Salluh, JIF. Understanding ICU Outcomes: Lessons From National ICU Registries. CRITICAL CARE MEDICINE. 2025; 53(11)DOI:10.1097/CCM.0000000000006853. PMID:40920041. IF:6.000(Q1/1D).
01/11/2025 Prevalence and Impact of Violence Against Healthcare Workers in Brazilian Emergency Departments: A National Survey
de Carvalho, JMD, McGuire, SS, Oliveira, LLR, Bellolio, F, Ranzani, OT, Besen, BAMP, Guimaraes, HP, Lunardi, MC, Mullan, AF, Hajjar, LA, Maia, IWA. Prevalence and Impact of Violence Against Healthcare Workers in Brazilian Emergency Departments: A National Survey. Western Journal of Emergency Medicine. 2025; 26(6)DOI:10.5811/westjem.45138. PMID:41380058. IF:2.000(Q2/4D).
01/11/2025 Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group
Brandao, M, Prisciandaro, E, Xenophontos, E, Mariolo, A, Sadeghi, AH, Filippi, AR, Levy, A, Bandura, A, Caramella, C, Dickhoff, C, de Margerie-Mellon, C, Faivre-Finn, C, Portik, D, Sanchez-Lorente, D, De Ruysscher, D, Smit, E, Gobbini, E, Fadel, E, Ruffini, E, Olmetto, E, Cortiula, F, Bahce, I, Houda, I, Opitz, I, Naidoo, J, Edwards, J, Remon, J, Benitez, JC, Trujillo, JC, Derks, J, Amrane, K, Hartemink, KJ, Stathopoulos, K, Hendriks, LEL, Iglesias, M, Occhipinti, M, Guckenberger, M, Levra, NG, Girard, N, Reguart, N, Mercier, O, Bironzo, P, Hofman, P, Petersen, RH, De Angelis, R, Abgral, R, Terrisse, S, Popat, S, Pierret, T, Blum, TG, Ricardi, U, Dionisi, V, Berghmans, T, Dingemans, AMC. Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group. LUNG CANCER. 2025; 209DOI:10.1016/j.lungcan.2025.108798. PMID:41108881. IF:4.400(Q1/2D).
01/11/2025 Transcatheter Tricuspid Valve Annuloplasty with the Cardioband System: A Step-by-Step Guide
Novembre, ML, Asmarats, L, Li, CHP, Santalo-Corcoy, M, Millán, X, Arzamendi, D. Transcatheter Tricuspid Valve Annuloplasty with the Cardioband System: A Step-by-Step Guide. Journal of Clinical Medicine. 2025; 14(21)DOI:10.3390/jcm14217772. PMID:41227168. IF:2.900(Q1/2D).
01/11/2025 Pacemaker Risk Stratification in Patients With Pre-existing Right Bundle Branch Block Undergoing Transcatheter Aortic Valve Replacement
Travieso, A, Nuche, J, Tirado-Conte, G, Cheema, AN, Tamargo, M, Muntané-Carol, G, Asmarats, L, Becerra-Muñoz, VM, Del Valle, R, Rivero, F, Pena, JCS, Cordon, CF, Martinez-Selles, M, Muñoz-Garcia, AJ, Lopez, D, Alonso-Briales, JH, Gonzalo, N, Alfonso, F, Arzamendi, D, Gomez-Hospital, JA, Rodés-Cabau, J, Nombela-Franco, L. Pacemaker Risk Stratification in Patients With Pre-existing Right Bundle Branch Block Undergoing Transcatheter Aortic Valve Replacement. CANADIAN JOURNAL OF CARDIOLOGY. 2025; 41(11)DOI:10.1016/j.cjca.2025.06.076. PMID:40623499. IF:5.300(Q1/2D).
01/11/2025 Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study
Puente, A, Turón, F, Martínez, J, Fortea, JI, Guerra, MH, Alvarado, E, Pons, M, Magaz, M, Llop, E, Alvarez-Navascués, C, Navarrete, AA, Berenguer, M, Masnou, H, Bañares, R, Casado, M, Ampuero, J, Rios, J, Saavedra, C, Blasi, A, Lisman, T, Figuero, CR, Huelin, P, Tellez, L, Arráez, DM, Rodriguez, M, Aguilera, V, Loste, MTA, Baiges, A, Hernandez-Gea, V, Perelló, C, Calleja, JL, Genescà, J, Villanueva, C, Gonzalez-Alayón, C, Albillos, A, Crespo, J, Garcia-Pagán, JC. Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study. JOURNAL OF HEPATOLOGY. 2025; 83(5)DOI:10.1016/j.jhep.2025.06.035. PMID:40691992. IF:33.000(Q1/1D).
01/11/2025 Executive summary. Screening, staging and follow-up of type 1 diabetes in preclinical stages: Consensus of the scientific societies SED, SEEN and SEEP
Martinez-Brocca, MA, Bellido, V, Cardona-Hernandez, R, Castaño, L, Conget, I, Fernández, A, Gila, ALG, Leiva-Gea, I, Mauricio, D. Executive summary. Screening, staging and follow-up of type 1 diabetes in preclinical stages: Consensus of the scientific societies SED, SEEN and SEEP. Endocrinologia Diabetes y Nutricion. 2025; 72(9)DOI:10.1016/j.endinu.2025.501639. PMID:41111054. IF:1.800(Q3/8D).
01/11/2025 Oxytocin in hypopituitarism: What do we know?
Aulinas, A, Lawson, EA. Oxytocin in hypopituitarism: What do we know?. Endocrinologia Diabetes y Nutricion. 2025; 72(9)DOI:. PMID:41173566. IF:1.800(Q3/8D).
01/11/2025 Unraveling the gut-fat-inflammation connection in Crohn's disease: A path to new therapeutic targets?
Giordano, A, Bastón-Rey, I, Madero, L, Brunet-Mas, E, Calafat, M. Unraveling the gut-fat-inflammation connection in Crohn's disease: A path to new therapeutic targets?. Gastroenterologia y Hepatologia. 2025; 48(9)DOI:10.1016/j.gastrohep.2025.502466. PMID:40378950. IF:1.900(Q3/7D).
01/11/2025 Colonoscopy in symptomatic patients: Validation of AEG-SEED prioritization criteria and added value of FIT. The endoprior study
Rivero-Sánchez, L, Castillo-Iturra, J, Garcia-Rodriguez, A, Zafra, BG, Redondo, PD, Rodriguez, HN, Ponce, M, San Juan, M, Barrera, PB, Seoane, A, Carrasco, MA, Zaffalon, D, Guarner, C, Murzi, M, Jover, R, Medina-Prado, L, Rubio, KA, Matias, DJ, Suárez, BG, Córdova, H, Fernández-Simón, A, Araujo, I, Ginés, A, Pellisé, M, Balaguer, F, Fernández-Esparrach, G. Colonoscopy in symptomatic patients: Validation of AEG-SEED prioritization criteria and added value of FIT. The endoprior study. Gastroenterologia y Hepatologia. 2025; 48(9)DOI:10.1016/j.gastrohep.2025.502471. PMID:40409590. IF:1.900(Q3/7D).
01/11/2025 Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis (vol 83, pg 70, 2025)
Fortea, JI, Alvarado-Tapias, E, Simbrunner, B, Ezcurra, I, Hernández-Gea, V, Aracil, C, Llop, E, Puente, A, Roig, C, Reiberger, T, Garcia-Pagan, JC, Calleja, JL, Ferrero-Gregori, A, Mandorfer, M, Villanueva, C, Crespo, J. Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis (vol 83, pg 70, 2025). JOURNAL OF HEPATOLOGY. 2025; 83(5)DOI:10.1016/j.jhep.2025.08.004. PMID:40914642. IF:33.000(Q1/1D).
01/11/2025 Mapping MSU crystal deposition within MTP joints in tophaceous gout: a dual-energy CT study
De Silva, C, Díaz-Torné, C, Gamble, G, Horne, A, Doyle, A, Stamp, LK, Dalbeth, N. Mapping MSU crystal deposition within MTP joints in tophaceous gout: a dual-energy CT study. RHEUMATOLOGY. 2025; 64(11)DOI:10.1093/rheumatology/keaf347. PMID:40581776. IF:4.400(Q1/1D).
01/11/2025 Age-standardized comparison of coronary artery disease, stroke incidence, and all-cause mortality between people living with HIV and the general population in Spain
Camps-Vilaró, A, Teira, R, Subirana, I, Dégano, IR, Domingo, P, Curran, A, Montero-Alonso, M, Romero, A, Marrugat, J, Galindo, MJ. Age-standardized comparison of coronary artery disease, stroke incidence, and all-cause mortality between people living with HIV and the general population in Spain. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2025; 160DOI:10.1016/j.ijid.2025.108061. PMID:40953693. IF:4.300(Q1/2D).